XML 31 R22.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue
3 Months Ended
May 02, 2025
Revenue from Contract with Customer [Abstract]  
Revenue

NOTE 13. REVENUE

 

Net Revenue

 

Product Sales

 

Revenue includes sales of merchandise and delivery revenue related to merchandise sold. Substantially all of the Company’s revenue is recognized when control of product passes to customers, which for the U.S. eCommerce, Europe eCommerce, Outfitters and Third Party distribution channels is when the merchandise is received by the customer and for the Retail distribution channel is at the time of sale in the store. The Company recognizes revenue, including shipping and handling fees billed to customers, in the amount expected to be received when control of the Company’s products transfers to customers, and is presented net of various forms of promotions, which range from contractually fixed percentage price reductions to sales returns, discounts, and other incentives that may vary in amount. Variable amounts are estimated based on an analysis of historical experience and adjusted as better estimates become available.

 

 

The Company’s revenue is disaggregated by distribution channel and geographic location. Revenue by distribution channel is presented in Note 12, Segment Reporting. Revenue by geographic location was:

 

 

 

13 Weeks Ended

 

(in thousands)

 

May 2, 2025

 

 

May 3, 2024

 

Net revenue:

 

 

 

 

 

 

United States

 

$

241,063

 

 

$

257,507

 

Europe

 

 

18,319

 

 

 

25,308

 

Other

 

 

1,826

 

 

 

2,656

 

Total Net revenue

 

$

261,208

 

 

$

285,471

 

 

Licensing Agreements

 

The Company generates royalty revenue from licensing the right to use its trademarks to third parties. The licensing agreements generally are exclusive to a product category, selling channel and/or geography, have terms in excess of one year, provide for annual guaranteed minimum royalties and, in most cases, include renewal options. In certain agreements, the licensee pays the Company a fulfillment fee for licensed product sold on the Company’s website and fulfilled from the Company’s distribution center. The trademark royalty revenue and fulfillment fee are included in Net revenue and reported in the Licensing distribution channel.

In exchange for providing these rights, the license agreements require the licensees to pay the Company a trademark royalty based on net sales as defined in the license agreements. The Company recognizes sales-based royalty revenue at the later of (i) when the related sales of the licensed product occur, or (ii) when the performance obligation has been satisfied, when the Company expects the annual guaranteed minimums will be met, where such provisions exist. If a sales-based royalty is not ultimately expected to exceed a contractually guaranteed minimum royalty amount, the minimum is recognized straight-line as revenue over the contractual period, if all other criteria of revenue recognition have been met. In certain licensing agreements, the Company agreed to provide marketing activities. The Company receives reimbursement for such services at cost. The amount of these reimbursements are recorded as a reduction of Selling and administrative expenses in the Condensed Consolidated Statements of Operations. The amount of these reimbursements was not material for the 13 weeks ended May 2, 2025 and May 3, 2024.

 

Contract Liabilities

 

Contract liabilities consist of payments received in advance of the transfer of control to the customer. As products are delivered and control transfers, the Company recognizes the deferred revenue in Net revenue in the Condensed Consolidated Statements of Operations. The following table summarizes the deferred revenue associated with payments received in advance of the transfer of control to the customer, reported in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheets, and amounts

recognized through Net revenue for each period presented. The majority of deferred revenue as of May 2, 2025 is expected to be recognized in Net revenue in the fiscal quarter ending August 1, 2025, as products are delivered to customers.

 

 

13 Weeks Ended

 

(in thousands)

 

May 2, 2025

 

 

May 3, 2024

 

Deferred revenue beginning of period

 

$

6,584

 

 

$

4,314

 

Deferred revenue recognized in period

 

 

(6,370

)

 

 

(4,100

)

Revenue deferred in period

 

 

4,835

 

 

 

9,126

 

Deferred revenue end of period

 

$

5,049

 

 

$

9,340

 

 

Revenue from gift cards is recognized when (i) the gift card is redeemed by the customer for merchandise, or (ii) as gift card breakage, an estimate of gift cards which will not be redeemed where the Company does not have a legal obligation to remit the value of the unredeemed gift cards to the relevant jurisdictions. Gift card breakage is recorded within Net revenue in the Condensed Consolidated Statements of Operations. Prior to their redemption, gift cards are recorded as a liability and included within Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheets. The liability is estimated based on expected breakage that considers historical patterns of redemption. The following table provides the reconciliation of the contract liability related to gift cards:

 

 

13 Weeks Ended

 

(in thousands)

 

May 2, 2025

 

 

May 3, 2024

 

Balance as of beginning of period

 

$

34,746

 

 

$

35,604

 

Gift cards issued

 

 

14,612

 

 

 

15,056

 

Gift cards redeemed

 

 

(15,310

)

 

 

(14,193

)

Gift card breakage

 

 

(684

)

 

 

(1,348

)

Balance as of end of period

 

$

33,364

 

 

$

35,119

 

 

Refund Liabilities

 

Refund liabilities, primarily associated with product sales returns and retrospective volume rebates, represent variable consideration and are estimated and recorded as a reduction to Net revenue based on historical experience. Refund liabilities, primarily associated with estimated product returns, were $13.3 million, $16.9 million and $15.2 million as of May 2, 2025, May 3, 2024 and January 31, 2025, respectively, and reported in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheets.